Wenyi Wu

701 total citations
38 papers, 537 citations indexed

About

Wenyi Wu is a scholar working on Molecular Biology, Ophthalmology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Wenyi Wu has authored 38 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 16 papers in Ophthalmology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Wenyi Wu's work include Retinal Development and Disorders (14 papers), Retinal Diseases and Treatments (13 papers) and CRISPR and Genetic Engineering (11 papers). Wenyi Wu is often cited by papers focused on Retinal Development and Disorders (14 papers), Retinal Diseases and Treatments (13 papers) and CRISPR and Genetic Engineering (11 papers). Wenyi Wu collaborates with scholars based in China, United States and Canada. Wenyi Wu's co-authors include Hetian Lei, Patrìcia A. D'Amore, Gaoen Ma, Xionggao Huang, Jingyuan Song, Luk H. Vandenberghe, Feng Zhang, Shizuo Mukai, Ru Xiao and Yanhui Yang and has published in prestigious journals such as Nature, Nature Communications and Diabetes.

In The Last Decade

Wenyi Wu

36 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenyi Wu China 13 352 171 99 77 48 38 537
Tatsuo Itakura United States 12 203 0.6× 178 1.0× 104 1.1× 33 0.4× 33 0.7× 21 463
Laryssa A. Huryn United States 14 283 0.8× 190 1.1× 109 1.1× 55 0.7× 19 0.4× 48 499
Xionggao Huang China 11 291 0.8× 189 1.1× 127 1.3× 57 0.7× 50 1.0× 26 455
Shiqi Yang China 10 348 1.0× 368 2.2× 230 2.3× 45 0.6× 43 0.9× 23 670
Ji Jin China 12 197 0.6× 174 1.0× 252 2.5× 55 0.7× 50 1.0× 19 569
Lijie Dong China 14 457 1.3× 149 0.9× 113 1.1× 37 0.5× 141 2.9× 38 696
Huey-Chuan Cheng Taiwan 14 260 0.7× 152 0.9× 212 2.1× 50 0.6× 38 0.8× 20 559
Manlin Jin United States 11 373 1.1× 306 1.8× 209 2.1× 31 0.4× 35 0.7× 12 615
Weijun An United States 11 355 1.0× 141 0.8× 43 0.4× 80 1.0× 23 0.5× 14 526
Bert Eussen Netherlands 11 317 0.9× 241 1.4× 29 0.3× 92 1.2× 36 0.8× 18 569

Countries citing papers authored by Wenyi Wu

Since Specialization
Citations

This map shows the geographic impact of Wenyi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyi Wu more than expected).

Fields of papers citing papers by Wenyi Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenyi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyi Wu. The network helps show where Wenyi Wu may publish in the future.

Co-authorship network of co-authors of Wenyi Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenyi Wu. A scholar is included among the top collaborators of Wenyi Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenyi Wu. Wenyi Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Fang, Xi Yang, Ze Wu, et al.. (2025). Melatonin Alleviates Retina Angiogenesis by Targeting Fibronectin and the VEGF Pathway. The FASEB Journal. 39(19). e71073–e71073.
3.
Liu, Dan, Jin Chen, Fang Chen, et al.. (2025). Fibronectin Mediates Endothelial-to-Mesenchymal Transition in Retina Angiogenesis. Investigative Ophthalmology & Visual Science. 66(3). 10–10. 1 indexed citations
4.
Chen, Fang, et al.. (2024). PI3Kδ Mediates Fibrosis by Patient-Derived Vitreous. Laboratory Investigation. 104(4). 102026–102026. 1 indexed citations
5.
Wu, Wenyi, Xiaobo Xia, Luosheng Tang, et al.. (2023). Phosphoinositide 3-kinase as a therapeutic target in angiogenic disease. Experimental Eye Research. 236. 109646–109646. 3 indexed citations
6.
Liu, Shikun, et al.. (2023). Nintedanib inhibits normal human vitreous-induced epithelial-mesenchymal transition in human retinal pigment epithelial cells. Biomedicine & Pharmacotherapy. 166. 115403–115403. 9 indexed citations
7.
Wu, Wenyi, Jing Cui, Joanne A. Matsubara, et al.. (2023). Ligand-independent activation of platelet-derived growth factor receptor β promotes vitreous-induced contraction of retinal pigment epithelial cells. BMC Ophthalmology. 23(1). 344–344. 2 indexed citations
8.
Wu, Wenyi & Hetian Lei. (2023). Genome Editing Inhibits Retinal Angiogenesis in a Mouse Model of Oxygen-Induced Retinopathy. Methods in molecular biology. 2678. 207–217. 1 indexed citations
9.
Wu, Wenyi, Gaoen Ma, Hui Qi, et al.. (2022). Genome Editing of Pik3cd Impedes Abnormal Retinal Angiogenesis. Human Gene Therapy. 34(1-2). 30–41. 6 indexed citations
10.
Qi, Hui, Fang Dong, Lu Chen, et al.. (2022). A Novel Role of IL13Rα2 in the Pathogenesis of Proliferative Vitreoretinopathy. Frontiers in Medicine. 9. 831436–831436. 2 indexed citations
11.
Wu, Wenyi, Pu Li, Endong Zhang, et al.. (2022). Application of team-based learning to ophthalmology in China. Frontiers in Public Health. 10. 922325–922325. 3 indexed citations
12.
Chen, Yanzhu, et al.. (2022). Exploring the Immune Infiltration Landscape and M2 Macrophage-Related Biomarkers of Proliferative Diabetic Retinopathy. Frontiers in Endocrinology. 13. 841813–841813. 30 indexed citations
13.
Chen, Yanzhu, Wenyi Wu, Bin Yan, et al.. (2022). PRRX1 Is a Novel Prognostic Biomarker and Facilitates Tumor Progression Through Epithelial–Mesenchymal Transition in Uveal Melanoma. Frontiers in Immunology. 13. 754645–754645. 16 indexed citations
14.
Yang, Yanhui, et al.. (2021). A robust method for protein depletion based on gene editing. Methods. 194. 3–11. 2 indexed citations
15.
Wu, Wenyi, et al.. (2021). Axl Is Essential for in-vitro Angiogenesis Induced by Vitreous From Patients With Proliferative Diabetic Retinopathy. Frontiers in Medicine. 8. 787150–787150. 7 indexed citations
16.
Wu, Wenyi, Yanhui Yang, Fei Yao, et al.. (2020). AAV-mediated in vivo genome editing in vascular endothelial cells. Methods. 194. 12–17. 8 indexed citations
17.
Xin, Tianyi, Haote Han, Wenyi Wu, et al.. (2019). Idelalisib inhibits vitreous-induced Akt activation and proliferation of retinal pigment epithelial cells from epiretinal membranes. Experimental Eye Research. 190. 107884–107884. 8 indexed citations
18.
Huang, Xionggao, Wenyi Wu, Gaoen Ma, et al.. (2017). Genome editing abrogates angiogenesis in vivo. Nature. 28 indexed citations
19.
Huang, Xionggao, Wenyi Wu, Gaoen Ma, et al.. (2017). Editing VEGFR2 Blocks VEGF-Induced Activation of Akt and Tube Formation. Investigative Ophthalmology & Visual Science. 58(2). 1228–1228. 53 indexed citations
20.
Huang, Xionggao, Wenyi Wu, Gaoen Ma, et al.. (2017). Genome editing abrogates angiogenesis in vivo. Nature Communications. 8(1). 112–112. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026